Chemotherapy Induced Neutropenia Treatment Market is driven by...

a adăugat un sunet Alte

2025-04-24 11:22:01 -

Chemotherapy Induced Neutropenia Treatment Market is driven by increasing cancer prevalence and rising demand for targeted therapies.

Chemotherapy-induced neutropenia (CIN) is a common side effect of cancer treatment that occurs when the number of neutrophils, a type of white blood cell, decreases due to chemotherapy. Chemotherapy-induced neutropenia Market can lead to severe complications, such as infections and fever, which may require hospitalization and interruption of cancer treatment. The growing incidence of cancer...

0 Commentarii 0 Distribuiri 234 Views 0 previzualizare